{
  "nctId": "NCT03209492",
  "briefTitle": "Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for \"Prostate Cancer\"",
  "officialTitle": "Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for \"Prostate Cancer\"",
  "protocolDocument": {
    "nctId": "NCT03209492",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2018-04-09",
    "uploadDate": "2019-04-08T21:56",
    "size": 1129178,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03209492/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 333,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2016-04-01",
    "completionDate": "2017-12-01",
    "primaryCompletionDate": "2017-12-01",
    "firstSubmitDate": "2017-07-04",
    "firstPostDate": "2017-07-06"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Participants with prostate cancer will be included.\n\nExclusion Criteria:\n\n* Participants with previous history of hypersensitivity to any of the ingredients of the drug or synthetic LH-RH or LH-RH derivatives",
    "healthyVolunteers": false,
    "sex": "MALE",
    "stdAges": [
      "CHILD",
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Percentage of Participants Who Had One or More Adverse Events",
        "timeFrame": "Up to Week 24"
      }
    ],
    "secondary": [
      {
        "measure": "Percentage of Participants Who Had One or More Adverse Reactions",
        "description": "Adverse drug reaction refers to adverse events related to the administered drug.",
        "timeFrame": "Up to Week 24"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 1,
      "otherCount": 0,
      "totalCount": 2
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-21T22:34:02.569Z",
  "dataSource": "ClinicalTrials.gov API v2 - Mass Collection"
}